Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1985-4-26
|
pubmed:abstractText |
DPDPE ([D-Pen2, D-Pen5]-Enkephalin) and DPLPE ([D-Pen2, L-Pen5]-Enkephalin) are conformationally-constrained cyclic analogs of enkephalin with high selectivity for delta opioid receptors. Intracerebroventricular (i.c.v.) administration of each analog acutely produces a complex EEG response in rats characterized by a dose-related increase in spectral power and HVSA (peak frequency of 5.0 Hz) during behavioral stupor, and a theta driving (5.25-8.0 Hz) associated with intense behavioral arousal. These effects were antagonized by high (10 mg/kg), but not low (1.0 mg/kg), doses of naloxone. Both analogs failed to cause EEG or convulsive seizures. In contrast, i.c.v. administration of DADLE ([D-Ala2, D-Leu5]-Enkephalin), an enkephalin analog with activity at both mu and delta binding sites, caused initial nonconvulsive EEG seizures followed by HVSA (3.0 Hz); theta driving was not evident. The incidence of the seizures was dose-related and antagonized by very low doses of naloxone (0.01-1.0 mg/kg). Collectively, the inability of DPDPE and DPLPE to cause seizure activity, and the marked sensitivity of DADLE-induced EEG seizures to naloxone, suggest that delta receptors are not directly responsible for DADLE-induced EEG seizure activity. Furthermore, these data implicate mu opioid receptors as the primary sites responsible for enkephalin-induced seizures.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, D-Penicillamine (2,5)-,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Leucine,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Leucine-2-Alanine,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, delta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0143-4179
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6099500-Animals,
pubmed-meshheading:6099500-Electroencephalography,
pubmed-meshheading:6099500-Enkephalin, D-Penicillamine (2,5)-,
pubmed-meshheading:6099500-Enkephalin, Leucine,
pubmed-meshheading:6099500-Enkephalin, Leucine-2-Alanine,
pubmed-meshheading:6099500-Enkephalins,
pubmed-meshheading:6099500-Male,
pubmed-meshheading:6099500-Rats,
pubmed-meshheading:6099500-Rats, Inbred Strains,
pubmed-meshheading:6099500-Receptors, Opioid,
pubmed-meshheading:6099500-Receptors, Opioid, delta,
pubmed-meshheading:6099500-Seizures
|
pubmed:year |
1984
|
pubmed:articleTitle |
Electroencephalographic assessment of the role of delta receptors in opioid peptide - induced seizures.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|